India Analytical Chromatography in Pharma Quality Control Market Size, Share and Trends Analysis Report – Industry Overview and Forecast to 2032

India Analytical Chromatography in Pharma Quality Control Market Size

• The India Analytical Chromatography in Pharma Quality Control Market size was valued at USD 338.9 Million in 2024 and is expected to reach USD 731.76 Million by 2032, at a CAGR of 10.10% during the forecast period
• The market growth is largely fueled by the increasing demand for high-precision and reliable analytical techniques in pharmaceutical quality control, ensuring compliance with stringent regulatory standards
• Furthermore, rising focus on drug safety, efficacy, and consistency is driving the adoption of advanced analytical chromatography solutions, thereby significantly boosting the India Analytical Chromatography in Pharma Quality Control Market's growth

India Analytical Chromatography in Pharma Quality Control Market Analysis

• Analytical chromatography systems, including HPLC, GC, and UPLC, are increasingly vital components of pharmaceutical quality control in India, driven by their precision in ensuring drug safety, efficacy, and regulatory compliance across generic and innovator pharmaceutical manufacturing. These systems are widely adopted in hospital laboratories, contract research organizations, and large-scale pharma quality control facilities
• The escalating demand for advanced analytical technologies is primarily fueled by the growing pharmaceutical manufacturing sector in India, increasing regulatory scrutiny, and rising emphasis on drug quality and patient safety. Expansion of clinical research and biopharma R&D activities further supports adoption
• India accounted for approximately 11.2% of the APAC India Analytical Chromatography in Pharma Quality Control Market in 2024, supported by increasing domestic pharmaceutical production, growing R&D investments, and government initiatives promoting quality standards and laboratory modernization
• The liquid chromatography segment dominated the largest market revenue share of 49.2% in 2024, owing to its versatility, high sensitivity, and widespread use in pharmaceutical analysis, including drug content, impurity profiling, and stability testing

Report Scope and India Analytical Chromatography in Pharma Quality Control Market Segmentation  

India Analytical Chromatography in Pharma Quality Control Market Trends

“Driving Productivity with Advanced Analytical Innovations”

• A significant and accelerating trend in the India Analytical Chromatography in Pharma Quality Control Market is the deepening integration of advanced analytical technologies, automation, and real-time monitoring systems. These technological enhancements are significantly improving the precision, reliability, and throughput of quality control processes in pharmaceutical manufacturing
• For instance, modern high-performance liquid chromatography (HPLC) systems with automated sample preparation and integrated detection modules enable laboratories to conduct complex analyses with minimal manual intervention. Similarly, ultra-performance liquid chromatography (UPLC) platforms provide faster run times, higher resolution, and reduced solvent consumption, offering more efficient quality control solutions
• Automation integration in analytical chromatography enables features such as automatic calibration, predictive maintenance alerts, and intelligent error detection, which optimize workflow efficiency and reduce human error. In addition, software-enabled platforms allow laboratories to track, manage, and analyze data in real-time, facilitating faster decision-making and regulatory compliance
• The seamless integration of advanced chromatography instruments with laboratory information management systems (LIMS) and data analytics platforms facilitates centralized control over quality control workflows. Through a unified interface, laboratory personnel can monitor multiple instruments, manage sample processing, and generate compliance reports, creating a standardized and automated operational environment
• This trend towards more intelligent, high-throughput, and interconnected analytical systems is fundamentally reshaping expectations for pharmaceutical quality control. Consequently, companies such as Agilent Technologies, Shimadzu, and Waters Corporation are developing next-generation chromatography solutions with features such as automated sample handling, high-sensitivity detection, and advanced data analytics capabilities
• The demand for advanced analytical chromatography systems is growing rapidly across pharmaceutical, biotech, and contract research organization (CRO) sectors, as stakeholders increasingly prioritize operational efficiency, accuracy, and regulatory compliance in quality control processes

India Analytical Chromatography in Pharma Quality Control Market Dynamics

Driver

“Growing Need Due to Stringent Regulatory Standards and Efficiency Requirements”

• The increasing prevalence of stringent regulatory standards by agencies such as the FDA, EMA, and CDSCO, coupled with the demand for faster and more accurate quality control, is a significant driver for the heightened adoption of advanced analytical chromatography systems
• For instance, in March 2023, Agilent Technologies launched the InfinityLab LC System, designed to enhance workflow efficiency with automated sample management and real-time data analytics, reinforcing operational compliance in pharmaceutical QC laboratories. Such strategic innovations by leading companies are expected to drive the Analytical Chromatography in Pharma Quality Control industry growth in the forecast period
• As pharmaceutical companies aim to ensure drug safety, efficacy, and batch-to-batch consistency, analytical chromatography instruments provide high-precision measurements, enabling robust quality control and faster product release
• Furthermore, the growing complexity of pharmaceutical formulations, including biologics, biosimilars, and combination drugs, is increasing the need for sophisticated analytical solutions capable of separating, identifying, and quantifying active pharmaceutical ingredients and impurities
• The demand for integrated systems with automation, high sensitivity, and advanced detection technologies is propelling the adoption of analytical chromatography in both large-scale pharmaceutical manufacturing and research-focused laboratories
• Investments in modern QC infrastructure, the need to reduce operational costs, and the push for high-throughput analysis are further contributing to market growth in India and globally

Restraint/Challenge

“High Initial Costs and Operational Complexity”

• The high initial investment required for advanced analytical chromatography instruments, including HPLC, UPLC, and GC-MS systems, poses a significant barrier to adoption for smaller pharmaceutical companies and academic laboratories
• Operational complexity associated with sophisticated instruments, including calibration, maintenance, and troubleshooting, requires skilled personnel and extensive training, which can limit deployment in resource-constrained environments
• Integration of multiple analytical techniques and software platforms can result in compatibility challenges, data management issues, and increased maintenance costs, restricting the smooth implementation of high-throughput systems
• While automation reduces manual labor, the upfront cost of robotic sample preparation and advanced detection modules remains high, potentially delaying adoption in developing regions
• Regulatory compliance also requires ongoing validation, documentation, and periodic audits, which adds to operational burden and total cost of ownership for analytical laboratories
• Unplanned instrument downtime or technical failures can disrupt critical quality control workflows, leading to production delays and increased operational risks, further emphasizing the need for robust maintenance and support
• Addressing these challenges through cost-effective solutions, modular system designs, and workforce training will be crucial for sustained market growth in the Analytical Chromatography in Pharma Quality Control sector

India Analytical Chromatography in Pharma Quality Control Market Scope

The market is segmented on the basis of products and techniques.

• By Products

On the basis of products, the India Analytical Chromatography in Pharma Quality Control Market is segmented into devices, consumables, and accessories. The devices segment dominated the largest market revenue share of 46.5% in 2024, driven by the increasing adoption of high-performance HPLC, UPLC, and GC systems in pharmaceutical manufacturing and quality control labs. Hospitals, contract research organizations, and large-scale pharma companies prefer devices for their precision, reproducibility, and compliance with regulatory standards. The market also sees strong demand due to ongoing pharmaceutical R&D, expansion of clinical testing facilities, and rising domestic drug production. Advanced automation features and integration with laboratory information management systems further enhance adoption. Growing awareness regarding drug safety, increasing exports, and government initiatives for laboratory modernization contribute to the devices segment’s dominant position.

The consumables segment is anticipated to witness the fastest CAGR of 11.8% from 2025 to 2032, fueled by the continuous need for columns, solvents, reagents, and sample kits. Rising pharmaceutical production, higher throughput testing, and recurring purchases for quality control drive growth. Consumables are particularly critical in laboratories focusing on high-volume testing, outsourcing R&D services, and contract manufacturing. Increasing demand for disposable consumables to reduce contamination risks and ensure compliance with Good Laboratory Practices (GLP) further accelerates growth.

• By Techniques

On the basis of techniques, the India Analytical Chromatography in Pharma Quality Control Market is segmented into thin-layer chromatography, liquid chromatography, gas chromatography, ion exchange chromatography, and others. The liquid chromatography segment dominated the largest market revenue share of 49.2% in 2024, owing to its versatility, high sensitivity, and widespread use in pharmaceutical analysis, including drug content, impurity profiling, and stability testing. Adoption is further supported by regulatory mandates requiring precise quantitative analysis in both bulk drugs and formulations. Expansion of pharmaceutical manufacturing hubs and CRO facilities across India strengthens the dominance of liquid chromatography.

The gas chromatography segment is expected to witness the fastest CAGR of 10.9% from 2025 to 2032, driven by its critical role in detecting volatile compounds, residual solvents, and impurities in drugs. The segment benefits from increasing adoption in R&D labs, quality control departments, and contract research organizations. Rising regulatory scrutiny, coupled with growing pharmaceutical exports, fuels investment in advanced GC systems. The shift toward automated and high-throughput GC techniques further accelerates the growth of this segment. In addition, the development of miniaturized and portable GC systems is expanding its application in on-site testing and field analysis, further supporting market growth.

India Analytical Chromatography in Pharma Quality Control Market Share

The Analytical Chromatography in Pharma Quality Control industry is primarily led by well-established companies, including:

• Waters Corporation (U.S.)
• Agilent Technologies
• Shimadzu Corporation (Japan)
• Thermo Fisher Scientific Inc. (U.S.)
• JASCO Corporation (Japan
• Bruker Corporation (U.S.)
• Metrohm AG (Switzerland
• Phenomenex Inc. (U.S.)
• Merck KGaA (Germany)
• Bio-Rad Laboratories (U.S.)
• PerkinElmer Inc. (U.S.)
• SIELC Technologies Inc. (U.S.)
• Eksigent Technologies (U.S.)
• Knauer Wissenschaftliche Geräte GmbH (Germany)
• Hitachi High-Technologies Corporation (Japan)

Latest Developments in India Analytical Chromatography in Pharma Quality Control Market

• In August 2025, Agilent Technologies, a leading provider of analytical instruments, inaugurated a new biopharma experience center in Hyderabad, India. The facility is designed to accelerate the development of life-saving medicines by offering cutting-edge technologies in chromatography, mass spectrometry, cell analysis, and lab informatics. It aims to foster collaboration between industry and academia, simulate real lab environments, and support faster research and development while adhering to international regulatory standards. This development underscores Agilent’s commitment to advancing pharmaceutical quality control capabilities in India
• In October 2025, India's drug regulator reported serious lapses in pharmaceutical quality control following the deaths of 17 children due to consuming toxic cough syrup containing diethylene glycol at levels nearly 500 times above the limit. Inspections revealed failures among multiple drugmakers to comply with testing requirements for both raw ingredients and finished products. This incident highlights the critical need for stringent analytical testing and quality assurance in pharmaceutical manufacturing to ensure public safety

SKU-27219